Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 5/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15667509 | 0.86 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| SCHEMBL11663394 | 0.83 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| SCHEMBL10040055 | 0.82 | MEN1 (0.51) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| SCHEMBL8847340 | 0.79 | MEN1 (0.71) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| SCHEMBL29227871 | 0.79 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| SCHEMBL5707674 | 0.79 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| SCHEMBL19426371 | 0.79 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| Tert-Butylbenzene SCHEMBL266495 | 0.79 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| SCHEMBL13295226 | 0.78 | MEN1 (0.48) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| SCHEMBL689297 | 0.75 | TDP1 (0.53) | MEN1KMT2ATSHRALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200317953-A1 | POLYETHERS CONTAINING NON-BISPHENOLIC CYCLIC GROUPS | SWIMC LLC (US) | 2020-10-08 | — | — | US | claimed |
| EP-2788398-B1 | SULFIDE EXTENDED EPOXY RESINS AND BARRIER COATINGS APPLICATIONS THEREOF | SUN CHEMICAL CORP (US) | 2018-07-25 | — | — | EP | claimed |
| CN-104039862-B | Sulfide-extended epoxy resin and application of barrier coating thereof | 太阳化学公司 | 2017-12-22 | — | — | CN | claimed |
| US-9624380-B2 | Sulfide extended epoxy resins and barrier coating applications thereof | SUN CHEMICAL CORPORATION (US) | 2017-04-18 | — | — | US | claimed |
| EP-3146009-A1 | POLYETHERS CONTAINING NON-BISPHENOLIC CYCLIC GROUPS | Valspar Sourcing, Inc. (US) | 2017-03-29 | — | — | EP | claimed |
| US-20170051177-A1 | POLYETHERS CONTAINING NON-BISPHENOLIC CYCLIC GROUPS | SWIMC LLC | 2017-02-23 | — | — | US | claimed |
| WO-2015179064-A1 | POLYETHERS CONTAINING NON-BISPHENOLIC CYCLIC GROUPS | VALSPAR SOURCING, INC. (US) | 2015-11-26 | — | — | WO | claimed |
| US-20140370220-A1 | OVERPRINT VARNISHES WITH NON-AQUOUS DISPERSIONS | SUN CHEMICAL CORPORATION (US) | 2014-12-18 | — | — | US | claimed |
| US-20140342091-A1 | SULFIDE EXTENDED EPOXY RESINS AND BARRIER COATING APPLICATIONS THEREOF | SUN CHEMICAL CORPORATION (US) | 2014-11-20 | — | — | US | claimed |
| EP-2788398-A2 | SULFIDE EXTENDED EPOXY RESINS AND BARRIER COATINGS APPLICATIONS THEREOF | Sun Chemical Corporation (US) | 2014-10-15 | — | — | EP | claimed |
| WO-2013090702-A2 | SULFIDE EXTENDED EPOXY RESINS AND BARRIER COATINGS APPLICATIONS THEREOF | SUN CHEMICAL CORPORATION (US) | 2013-06-20 | — | — | WO | claimed |
| CN-114525072-A | Polyethers containing cyclic groups other than bisphenols | 宣伟投资管理有限公司 | 2022-05-24 | — | — | CN | disclosed |
| US-20200317953-A1 | POLYETHERS CONTAINING NON-BISPHENOLIC CYCLIC GROUPS | SWIMC LLC (US) | 2020-10-08 | — | — | US | disclosed |
| US-10793742-B2 | Polyethers containing non-bisphenolic cyclic groups | VALSPAR SOURCING, INC. (US) | 2020-10-06 | — | — | US | disclosed |
| EP-2788398-B1 | SULFIDE EXTENDED EPOXY RESINS AND BARRIER COATINGS APPLICATIONS THEREOF | SUN CHEMICAL CORP (US) | 2018-07-25 | — | — | EP | disclosed |
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-10-22 | — | — | US | disclosed |
| CN-101309992-A | Mercaptan-hardened epoxy polymer compositions and processes for making and using same | CHEVRON PHILLIPS CHEMICAL CO (US) | 2008-11-19 | — | — | CN | disclosed |
| EP-1940992-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | Chevron Phillips Chemical Company LP (US) | 2008-07-09 | — | — | EP | disclosed |
| US-20070112100-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY, LP | 2007-05-17 | — | — | US | disclosed |
| WO-2007022217-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | TST, HHAT, GSTO1 | MEN1 4361/4885KMT2A 3148/4885TSHR 4571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.